Investigators searched publication databases for randomized controlled trials evaluating cognitive training and remediation interventions among patients with MDD.
Your search for major depressive disorder returned 39 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Researchers seek to evaluate whether trauma-focused therapy adjunctive to treatment as usual (TAU) leads to a greater reduction of depressive symptoms posttreatment vs TAU exclusively in patients with major depressive disorder with childhood trauma.
Researchers evaluated the efficacy of dextromorphan-bupropion among patients with major depressive disorder and comorbid anxiety.
Better baseline cardiovascular health and improvement in cardiovascular health over seven years tied to lower 19-year risk for depression
The Alpha-Stim-D trial was a noncommercial, multicenter, randomly assigned, parallel group, double-blind trial conducted at 25 primary care practices in the United Kingdom.
Investigators sought to assess associations for US Army soldiers bullied by fellow soldiers with mental health outcomes.
American College of Physicians recommends monotherapy with cognitive therapy or second-generation antidepressant for patients in acute phase of moderate-to-severe depression
Deep learning, multidiagnostic model shows high accuracy before clinical examination
Researchers compared grey matter volume patterns in adult patients with attention-deficit/hyperactivity disorder and bipolar disorder.
Researchers compared the white matter networks of patients with remitted major depressive disorder and remitted bipolar disorder to find disease-specific alterations.
However, no corresponding increase seen in mental health treatment
Researchers sought to determine the time course and state dependency of serum amyloid-beta levels in older patients with depression.
Adults with major depressive disorder and a history of childhood trauma can still benefit from recommended depression treatments.
Authors say findings similar across people with schizophrenia, major depressive disorder, and bipolar disorder in three distinct geographic settings
Investigators sourced data for this study from the Stockholm Major Depressive Disorder Cohort. Between 2010 and 2018, all patients in the Stockholm region who met the criteria for MDD were enrolled in the cohort.
However, expansion of telehealth yielded net increase in care for major depressive disorder, anxiety, and adjustment disorder
Researchers assessed characteristics and correlates of metabolic syndrome in adolescents with major depressive disorder or bipolar disorder depression.
Patients who had treatment-naïve MDD were recruited in the US between 2007 and 2013 for the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study.
In this review, authors focused on the psychiatric issues that often accompany migraine and the effects of botulinum toxin A on migraine.
Treatment-resistant depression episodes tied to more psychiatric comorbid conditions, health care utilization, self-harm, and all-cause mortality
Investigators looked into which treatment fared better for patients with anxiety disorders: a mindfulness-based stress reduction intervention or escitalopram.
Being married, having a confidant associated with better mental health with COPD
Reduction in caregiver depressive symptoms may have positive impact on child asthma outcomes, partially mediated by child depressive symptom severity
What is the link between multiple sclerosis and depression, and how can you help patients with their mental health?
Researchers examined correlations between suicidal ideation and suicide attempt history in patients with treatment-resistant depression following ketamine infusion.
Screening for MDD recommended for teens aged 12 to 18 years; anxiety screening recommended for children aged 8 to 18 years
Researchers sought to evaluate the relationship among insomnia symptoms, inflammation, and risk for stroke.
Researcher sought to assess how timing, frequency, and maintenance of physical activity in adulthood, over the span of 30 years, is associated with cognitive function later in life.
Solanezumab is a humanized monoclonal antibody designed to increase clearance of soluble amyloid beta (Aβ) from the brain by binding to aggregated forms of Aβ.
According to a new poll, more than 90% of adults who reported they get good sleep were also free of depressive symptoms.
Latest News Your top articles for SundayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses